Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Baccarani

Showing results (191-200 of 381) with videos related to

Pageof 39
Sort By:
Bone Marrow Transplantation|April 5, 2005
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II studyF Bonifazi, G Bandini, M Stanzani, et al.
Haematologica|May 1, 1994
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemiaA Michelutti, M Michieli, D Damiani, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Chronic myelogenous leukemiaB J Druker, C L Sawyers, R Capdeville, et al.
Haematologica|January 1, 1972
[Lymphadenographic and histopathological comparison of lumbo-aortic lymph nodes in Hodgkin's lymphoma]A Zanetti, P Sassi, P Palmieri, et al.
Haematologica|September 1, 1995
Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvestsC Rinaldi, C Savignano, F Silvestri, et al.
Experimental and Molecular Pathology|August 1, 1994
Ultrastructural analysis of skin and aorta from a patient with Menkes diseaseI Pasquali-Ronchetti, M Baccarani-Contri, R D Young, et al.
La Radiologia Medica|February 1, 1978
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)]L Babini, R Sciascia, M Baccarani, et al.
Haematologica|July 1, 1993
DNA-topoisomerase I and II: biologic features and their role in drug resistanceD Russo, J P Marie, A Delmer, et al.
Tumori|December 31, 1994
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's diseaseF Silvestri, R Fanin, M Velisig, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemiaF Pea, D Russo, M Michieli, et al.
Pageof 39

Showing results (191-200 of 381) with videos related to

Sort By:
Pageof 39
Bone Marrow Transplantation|April 5, 2005
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II studyF Bonifazi, G Bandini, M Stanzani, et al.
Haematologica|May 1, 1994
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemiaA Michelutti, M Michieli, D Damiani, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Chronic myelogenous leukemiaB J Druker, C L Sawyers, R Capdeville, et al.
Haematologica|January 1, 1972
[Lymphadenographic and histopathological comparison of lumbo-aortic lymph nodes in Hodgkin's lymphoma]A Zanetti, P Sassi, P Palmieri, et al.
Haematologica|September 1, 1995
Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvestsC Rinaldi, C Savignano, F Silvestri, et al.
Experimental and Molecular Pathology|August 1, 1994
Ultrastructural analysis of skin and aorta from a patient with Menkes diseaseI Pasquali-Ronchetti, M Baccarani-Contri, R D Young, et al.
La Radiologia Medica|February 1, 1978
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)]L Babini, R Sciascia, M Baccarani, et al.
Haematologica|July 1, 1993
DNA-topoisomerase I and II: biologic features and their role in drug resistanceD Russo, J P Marie, A Delmer, et al.
Tumori|December 31, 1994
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's diseaseF Silvestri, R Fanin, M Velisig, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemiaF Pea, D Russo, M Michieli, et al.
Pageof 39